Quest Diagnostics (DGX) Cash Flow Statement

Click line-items for a historical chart and %

Net income	529M
Depreciation and amortization	186M
Provision for doubtful accounts	242M
Deferred income tax provision (benefit)	19M
Stock-based compensation expense	52M
Excess tax benefits from stock-based compensation arrangements
Provision for special charge
Other, net	-15M
Accounts receivable
Accounts payable and accrued expenses	43M
Settlement of special charge
Income taxes payable	74M
Other assets and liabilities, net	15M
Net cash provided by operating activities	765M
Business acquisitions, net of cash acquired	-139M
Sale of securities acquired in business acquisition
Capital expenditures	-165M
Increase in investments and other assets	-11M
Net cash used in investing activities	-45M
Proceeds from borrowings
Repayments of Debt	-1.72B
Purchases of treasury stock	-440M
Exercise of stock options	63M
Excess tax benefits from stock-based compensation arrangements
Dividends paid	-168M
Distributions to noncontrolling interests	-31M
Other financing activities	-8M
Net cash provided by (used in) financing activities	-447M
Net change in cash and cash equivalents	273M
Cash and cash equivalents, beginning of period	133M
Cash and cash equivalents, end of period	406M

Entities mentioned with DGX

View All Entities